167 related articles for article (PubMed ID: 38201944)
21. PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.
Kirschner AN; Wang J; van der Meer R; Anderson PD; Franco-Coronel OE; Kushner MH; Everett JH; Hameed O; Keeton EK; Ahdesmaki M; Grosskurth SE; Huszar D; Abdulkadir SA
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505253
[TBL] [Abstract][Full Text] [Related]
22. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB.
Trtkova K; Paskova L; Matijescukova N; Strnad M; Kolar Z
Neoplasma; 2010; 57(5):406-14. PubMed ID: 20568894
[TBL] [Abstract][Full Text] [Related]
23. The antileukemic effects of saffron (Crocus sativus L.) and its related molecular targets: A mini review.
Moradzadeh M; Kalani MR; Avan A
J Cell Biochem; 2019 Apr; 120(4):4732-4738. PubMed ID: 30644127
[TBL] [Abstract][Full Text] [Related]
24. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts.
El-Zawahry A; McKillop J; Voelkel-Johnson C
BMC Cancer; 2005 Jan; 5():2. PubMed ID: 15638938
[TBL] [Abstract][Full Text] [Related]
25. Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirus.
Khavari A; Bolhassani A; Alizadeh F; Bathaie SZ; Balaram P; Agi E; Vahabpour R
Arch Virol; 2015 Feb; 160(2):499-508. PubMed ID: 25395243
[TBL] [Abstract][Full Text] [Related]
26. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines.
Tavakkol-Afshari J; Brook A; Mousavi SH
Food Chem Toxicol; 2008 Nov; 46(11):3443-7. PubMed ID: 18790714
[TBL] [Abstract][Full Text] [Related]
27. Identification of the therapeutic mechanism of the saffron crocus on glioma through network pharmacology and bioinformatics analysis.
Yang X; Man D; Zhao P; Li X
Med Oncol; 2023 Sep; 40(10):296. PubMed ID: 37691037
[TBL] [Abstract][Full Text] [Related]
28. DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation.
Zhu A; Hopkins KM; Friedman RA; Bernstock JD; Broustas CG; Lieberman HB
Carcinogenesis; 2021 Feb; 42(2):220-231. PubMed ID: 32780107
[TBL] [Abstract][Full Text] [Related]
29. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
30. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
Shanmugam MK; Rajendran P; Li F; Nema T; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Ho PC; Hui KM; Sethi G
J Mol Med (Berl); 2011 Jul; 89(7):713-27. PubMed ID: 21465181
[TBL] [Abstract][Full Text] [Related]
31. Saffron and Its Major Ingredients' Effect on Colon Cancer Cells with Mismatch Repair Deficiency and Microsatellite Instability.
Amin A; Farrukh A; Murali C; Soleimani A; Praz F; Graziani G; Brim H; Ashktorab H
Molecules; 2021 Jun; 26(13):. PubMed ID: 34202689
[TBL] [Abstract][Full Text] [Related]
32. Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer.
Kuefer R; Hofer MD; Altug V; Zorn C; Genze F; Kunzi-Rapp K; Hautmann RE; Gschwend JE
Br J Cancer; 2004 Jan; 90(2):535-41. PubMed ID: 14735205
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets.
Narayanan BA; Narayanan NK; Re GG; Nixon DW
Int J Cancer; 2003 Mar; 104(2):204-12. PubMed ID: 12569576
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of a Crocus sativus Extract on Burn Wounds in Rats.
Alemzadeh E; Oryan A
Planta Med; 2018 Nov; 84(16):1191-1200. PubMed ID: 29791931
[No Abstract] [Full Text] [Related]
37. Inhibition of genotoxicity by saffron (Crocus sativus L.) in mice.
Premkumar K; Abraham SK; Santhiya ST; Gopinath PM; Ramesh A
Drug Chem Toxicol; 2001 Nov; 24(4):421-8. PubMed ID: 11665650
[TBL] [Abstract][Full Text] [Related]
38. Crocus sativus stigma extract and its major constituent crocin possess significant antiproliferative properties against human prostate cancer.
D'Alessandro AM; Mancini A; Lizzi AR; De Simone A; Marroccella CE; Gravina GL; Tatone C; Festuccia C
Nutr Cancer; 2013; 65(6):930-42. PubMed ID: 23909737
[TBL] [Abstract][Full Text] [Related]
39. Saffron (Crocus sativus) and its constituents for pain management: A review of current evidence.
Pourbagher-Shahri AM; Forouzanfar F
Phytother Res; 2023 Nov; 37(11):5041-5057. PubMed ID: 37528638
[TBL] [Abstract][Full Text] [Related]
40. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
